| Views | |
|---|---|
| Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells | 166 |
| June 2025 | July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | December 2025 | |
|---|---|---|---|---|---|---|---|
| Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells | 3 | 3 | 1 | 10 | 33 | 24 | 2 |
| Views | |
|---|---|
| 2022_Berlak_etal.pdf | 57 |
